Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 24
Filter
1.
Open Forum Infect Dis ; 10(7): ofad333, 2023 Jul.
Article in English | MEDLINE | ID: mdl-37426950

ABSTRACT

Background: The kidney is a common target for human immunodeficiency virus (HIV), making renal disease a common noninfectious complication of HIV. Microalbuminuria is an important marker that can detect early renal damage. Timely detection of microalbuminuria is important to initiate renal management and stop the progression of renal dysfunction in people with HIV. Limited data are available about renal abnormalities in people with perinatal HIV infection. The objective of this study was to determine the prevalence of microalbuminuria in a cohort of perinatally HIV-infected children and young adults receiving combination antiretroviral therapy and investigate correlations between microalbuminuria and clinical and laboratory findings. Methods: This was a retrospective study of 71 patients with HIV followed in an urban pediatric HIV clinic in Houston, Texas, between October 2007 and August 2016. Demographic, clinical, and laboratory data were compared between subjects with persistent microalbuminuria (PM) and those without. PM is defined as a microalbumin-to-creatinine ratio ≥30 mg/g on at least 2 occasions separated by at least 1 month. Results: Sixteen of 71 patients (23%) met the definition of PM. In univariate analysis, patients with PM had significantly higher CD8+ T-cell activation and lower CD4+ T-cell nadir. Multivariate analysis demonstrated increased microalbuminuria to be independently associated with older age and CD8+ T-cell activation measured as CD8+HLA-DR+ T-cell percentage. Conclusions: Older age and increased activation of CD8+HLA-DR+ on T cells correlate with presence of microalbuminuria in this cohort of HIV-infected patients.

3.
MMWR Morb Mortal Wkly Rep ; 71(49): 1547-1549, 2022 Dec 09.
Article in English | MEDLINE | ID: mdl-36480462

ABSTRACT

In late August 2021, a boy aged 7 years was bitten by a bat while he was playing outside his apartment home in Medina County, Texas. He informed his parents; however, no rabies postexposure prophylaxis (PEP) was sought because there were no visible bite marks, and the family was unaware that contact with a bat, including in the absence of visible bite marks, might cause rabies. Approximately 2 months later, the child was hospitalized for altered mental status, seizures, and hypersalivation and ultimately received a diagnosis of rabies. Experimental therapies were attempted; however, the child died 22 days after symptom onset. Fifty-seven persons who met criteria for suspected or known exposure to infectious secretions in this case were advised to consult with a medical provider about the need for rabies PEP in accordance with Advisory Committee on Immunization Practices (ACIP) guidelines (1). Rabies, an acute, progressive neuroencephalitis, is nearly always fatal. Although dogs are the most common source of human rabies deaths worldwide and account for an estimated 59,000 annual cases of human rabies globally (2), bats are the most common source of domestically acquired rabies in the United States and have been implicated in 31 (81.6%) of 38 human infections since 2000 (3). Attempts to prevent death or poor neurologic outcomes once rabies symptoms develop have been largely unsuccessful (4). Administration of rabies PEP, comprising rabies immunoglobulin and a series of doses of rabies vaccine, is critical to preventing rabies after an exposure; enhanced public education about the risk posed by bats, and the availability of PEP to prevent rabies, is needed.


Subject(s)
Parents , Child , Humans , Dogs , Animals , Texas/epidemiology
6.
Case Rep Pediatr ; 2021: 8907944, 2021.
Article in English | MEDLINE | ID: mdl-34900356

ABSTRACT

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first reported in December 2019 in Wuhan, China. This novel coronavirus has been responsible for a pandemic that continues to devastate nations worldwide. COVID-19, like other viruses, causes pneumonia. However, unlike other viral respiratory tract infections such as influenza, bacterial coinfection in COVID-19 patients has uncommonly been described in adult and pediatric patients. We report a case of Streptococcus pneumoniae and COVID-19 coinfection in a previously healthy 4-year-old child.

7.
Pediatr Infect Dis J ; 39(12): e447-e449, 2020 12.
Article in English | MEDLINE | ID: mdl-33060516

ABSTRACT

Multisystem inflammatory syndrome in children is a severe illness associated with the SARS-CoV-2 pandemic that possesses features overlapping with other pediatric diseases causing systemic inflammation. Significant diagnostic and treatment uncertainty remain, and clinicians should maintain a broad differential when evaluating patients for multisystem inflammatory syndrome in children, as antibiotic-susceptible infections such as murine typhus may present similarly.


Subject(s)
COVID-19/complications , Disease Outbreaks , Systemic Inflammatory Response Syndrome/diagnosis , Typhus, Endemic Flea-Borne/diagnosis , Typhus, Endemic Flea-Borne/epidemiology , Adolescent , Animals , Biomarkers , COVID-19/diagnosis , COVID-19/epidemiology , COVID-19/etiology , Child , Humans , Mice , Pandemics , Symptom Assessment , Systemic Inflammatory Response Syndrome/epidemiology , Systemic Inflammatory Response Syndrome/etiology , Typhus, Endemic Flea-Borne/etiology , Typhus, Endemic Flea-Borne/transmission
8.
Case Rep Infect Dis ; 2019: 6568732, 2019.
Article in English | MEDLINE | ID: mdl-30805230

ABSTRACT

Invasive group A Streptococcus infections are associated with diverse presentations. We report a severe, rare case of GAS infection with dissemination including endocarditis and STSS. While whole genome sequencing of blood and pharyngeal isolates did not reveal any unique features attributable to the severe presentation, our approach serves as a template for investigation of severe manifestations of common infections.

9.
Emerg Infect Dis ; 23(6): 1037-1038, 2017 06.
Article in English | MEDLINE | ID: mdl-28518035

ABSTRACT

Infection with Angiostrongylus cantonensis roundworms is endemic in Southeast Asia and the Pacific Basin. A. cantonensis meningitis and myelitis occurred in summer 2013 in a child with no history of travel outside of Texas, USA. Angiostrongyliasis is an emerging neurotropic helminthic disease in Texas and warrants increased awareness among healthcare providers.


Subject(s)
Angiostrongylus cantonensis/pathogenicity , Antibodies, Helminth/blood , Immunoglobulin G/blood , Meningitis/diagnosis , Myelitis/diagnosis , Strongylida Infections/diagnosis , Albendazole/therapeutic use , Angiostrongylus cantonensis/physiology , Animals , Anthelmintics/therapeutic use , Child , Female , Humans , Meningitis/cerebrospinal fluid , Meningitis/drug therapy , Meningitis/parasitology , Myelitis/cerebrospinal fluid , Myelitis/drug therapy , Myelitis/parasitology , Strongylida Infections/cerebrospinal fluid , Strongylida Infections/drug therapy , Strongylida Infections/parasitology , Texas , Treatment Outcome
10.
Pediatr Infect Dis J ; 36(9): e219-e222, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28419006

ABSTRACT

We demonstrate for perinatally HIV-infected children and adolescents receiving combined antiretroviral therapy and in good clinical status with respect to HIV disease that high concentrations of interferon-gamma-inducible protein 10 associate with increased exhausted memory B cells.


Subject(s)
B-Lymphocytes/immunology , Chemokine CXCL10/blood , HIV Infections/blood , HIV Infections/epidemiology , Adolescent , Adult , Chemokine CXCL10/immunology , Child , Cross-Sectional Studies , Female , HIV Infections/immunology , HIV Infections/physiopathology , HIV-1/immunology , Humans , Infant, Newborn , Middle Aged , Phenotype , Pregnancy
11.
Am J Trop Med Hyg ; 95(4): 970-972, 2016 Oct 05.
Article in English | MEDLINE | ID: mdl-27527632

ABSTRACT

Measurements of CD4+CD31+ cells gave results consistent with those expected for recent thymus emigrant (RTE) CD4+ cells. The method was markedly simpler than established procedures for measurement of CD4+ RTE cells and is usable in locations with limited facilities and budgets.


Subject(s)
CD4 Lymphocyte Count/methods , CD4-Positive T-Lymphocytes/metabolism , HIV Infections/blood , Platelet Endothelial Cell Adhesion Molecule-1/metabolism , Adolescent , Adult , Child , Child, Preschool , Female , Humans , Infant , Infant, Newborn , Male , Retrospective Studies , Thymus Gland/cytology , Young Adult
12.
Clin Infect Dis ; 62(8): 1029-1035, 2016 Apr 15.
Article in English | MEDLINE | ID: mdl-26908808

ABSTRACT

BACKGROUND: Robust immune restoration in human immunodeficiency virus (HIV)-positive patients is dependent on thymic function. However, few studies have investigated thymic function and its correlation with disease progression over time in HIV-positive patients. METHODS: In this longitudinal prospective study, we followed 69 HIV-positive patients who were perinatally infected. Peripheral blood mononuclear cells were stained with monoclonal anti-CD4 and anti-CD31 and recent thymic emigrants (CD4+recently emigrated from the thymus (RTE), CD4+CD31+) quantified by flow cytometry. Statistical analysis used Wilcoxon rank sum test, Kruskal-Wallis, Spearman correlation, and Kaplan-Meier estimates; Cox regression models were performed for the longitudinal analysis. RESULTS: Median age of HIV positive patients enrolled was 13 years (interquartile range [IQR], 8.6). CD4+RTE% decreased with age and was higher in females. Median CD4+RTE% was 53.5%, IQR, 22.9. CD4+RTE% was closely related to CD4+% and absolute counts but independent of viral load and CD8+CD38+%. Antiretroviral compliance as well as higher nadir CD4+% were associated with higher CD4+RTE%. Low CD4+RTE% predicted poor progression of VL and CD4+% over time. CONCLUSIONS: CD4+RTE% predicts disease progression and may reflect history of disease in HIV-positive patients and adolescents. They are easy to measure in the clinical setting and may be helpful markers in guiding treatment decisions.


Subject(s)
CD4 Lymphocyte Count , CD4-Positive T-Lymphocytes , Disease Progression , HIV Infections/immunology , Thymus Gland/immunology , Adolescent , Child , Child, Preschool , Female , HIV Infections/drug therapy , HIV Infections/virology , HIV-1/immunology , HIV-1/physiology , Humans , Infectious Disease Transmission, Vertical , Longitudinal Studies , Male , Platelet Endothelial Cell Adhesion Molecule-1/immunology , Pregnancy , Prospective Studies , Texas/epidemiology , Thymus Gland/cytology , Viral Load , Young Adult
13.
J Infect ; 72(3): 353-61, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26711193

ABSTRACT

OBJECTIVES: Individuals with perinatally acquired HIV infection have benefited from antiretroviral therapy. However, they often have complex patterns of major resistance mutations that limit the effectiveness of available antiretroviral medications. Knowledge of incidence rates of major antiretroviral resistance mutations should provide a benchmark enabling comparisons of different HIV care delivery modalities. METHODS: We test the hypothesis that incidence rate of major antiretroviral resistance mutations will decline with improvement in HIV care between 1998 and 2009 to NRTI, NNRTI, PI and triple class resistance in perinatally HIV infected individuals. Logistic regression is used to evaluate predictors of single and triple class resistance. RESULTS: Sixty-six individuals are included from a total population of 97 perinatally HIV infected individuals. The incidence rate of NRTI, NNRTI, PI and triple class resistance decreases with decreasing age in parallel with the introduction of new HIV treatment regimens. The youngest children (born 2000-2007) are free of triple class resistance. Mono-therapy associates with major resistance mutations to NRTI (OR 8.7, CI 1.5-50.9, P 0.02); NNRTI exposure associates with major resistance mutations to NNRTI (OR 24.4, CI 5.7-104.5, P 0.01) and triple class resistance (OR 10.7, CI 1.8-67.1, P 0.01). Cumulative viral load is an important predictor of PI resistance (OR 4.0, CI 1.3-12.3, P 0.02). CONCLUSIONS: There is a progressive decrease in the incidence rate of major resistance mutations to antiretroviral drugs and triple class resistance from the oldest to the youngest birth cohort; where adolescents have the highest risk of harboring resistant viruses. The incidence rate of major antiretroviral resistance mutations provides a benchmark for the comparative measurement of effectiveness of different HIV care delivery modalities.


Subject(s)
Anti-HIV Agents/pharmacology , Anti-HIV Agents/therapeutic use , Drug Resistance, Viral , HIV Infections/drug therapy , HIV Infections/virology , HIV-1/drug effects , Adolescent , Child , Female , HIV Infections/epidemiology , Humans , Incidence , Male , Retrospective Studies
14.
Pediatr Infect Dis J ; 33(6): e151-7, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24836756

ABSTRACT

BACKGROUND: Despite dramatic decreases in rates of perinatal mother-to-child-transmission (PMTCT) of HIV in the United States, rates in some groups remain above the national average. Our objective was to examine factors contributing to a high rate of PMTCT of HIV. METHODS: We conducted a retrospective chart review of HIV-exposed infants and their mothers referred to the University of Texas-Houston Pediatric HIV Clinic from January 2000 to June 2007. RESULTS: Of 367 newborns studied, 22 (6%) acquired HIV infection perinatally. Associated risk factors included inadequate prenatal care, failure to receive antiretroviral therapy during pregnancy, detectable viral load and intravenous drug abuse. CONCLUSIONS: The composite rate of PMTCT in this high risk cohort was at least 3-fold higher than expected from the current standard of care. Reduction of rates of PMTCT in our population will require ensuring access to appropriate prenatal care, including delivery of antiretroviral therapy and addressing issues of illicit drug use.


Subject(s)
HIV Infections/epidemiology , HIV Infections/transmission , Infectious Disease Transmission, Vertical/statistics & numerical data , Pregnancy Complications, Infectious/epidemiology , Adolescent , Adult , Anti-HIV Agents/administration & dosage , Female , HIV Infections/drug therapy , Humans , Infant, Newborn , Pregnancy , Pregnancy Complications, Infectious/drug therapy , Retrospective Studies , Risk Factors , Texas/epidemiology , Young Adult
15.
J Antimicrob Chemother ; 68(10): 2344-8, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23732699

ABSTRACT

BACKGROUND: Etravirine is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) with reduced cross-resistance to first-generation NNRTIs. Because many perinatally HIV-infected patients have been treated with first-generation NNRTIs, they may have acquired resistance-associated mutations to etravirine (RAMe). METHODS: We determined for the interval 1998-2009 the prevalence and factors associated with the presence of RAMe. RESULTS: Twenty-three of 66 (34.8%) children had RAMe; the most common were 181C (19.6%), 190A (7.5%), 98G (6%), 106I (4.5%), 179D (4.5%), 100I (3%), 181I (1.5%), 138A (1.5%) and 179T (1.5%). Eleven children with RAMe (17%) had a mutation score between 2.5 and 3.5 and 1 (1.5%) a score ≥4, indicating an intermediate and reduced response to etravirine. For each 1% increase in CD4% there is a 7% decrease in the odds of RAMe (OR 0.93; 95% CI 0.88-0.97; P < 0.01). History of nevirapine use (OR 8.95; 95% CI 2.31-34.73; P < 0.01) and Hispanic ethnicity (OR 4.76; 95% CI 1.03-21.87; P = 0.04) are significantly associated with risk of RAMe. CONCLUSIONS: RAMe are present and common among antiretroviral-experienced perinatally HIV-infected children without previous exposure to etravirine. This could limit the efficacy of etravirine-based regimens. In addition, our results underscore the importance of taking previous history of nevirapine into account for combined antiretroviral therapy regimens that contain etravirine.


Subject(s)
Anti-HIV Agents/administration & dosage , Anti-HIV Agents/pharmacology , Drug Resistance, Viral , HIV Infections/drug therapy , HIV/drug effects , Pyridazines/administration & dosage , Pyridazines/pharmacology , Child , Child, Preschool , Cohort Studies , Female , HIV/genetics , HIV/isolation & purification , HIV Infections/virology , Humans , Male , Mutation, Missense , Nitriles , Prevalence , Pyrimidines , Retrospective Studies , Risk Factors
16.
Anaerobe ; 22: 118-20, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23664903

ABSTRACT

Severe oropharyngeal infection can result in Lemierre's disease, a syndrome with high mortality secondary to inflammation and thrombosis of cervical and intracranial veins with involvement of contiguous structures; however arterial involvement is rare. We report a case of Lemierre's disease in a 12 year old boy with severe narrowing of the left cavernous carotid artery.


Subject(s)
Carotid Artery, Internal , Carotid Stenosis/microbiology , Fusobacterium Infections/microbiology , Fusobacterium necrophorum/isolation & purification , Lemierre Syndrome/complications , Child , Fusobacterium Infections/diagnosis , Humans , Male
18.
Biomédica (Bogotá) ; 29(4): 506-512, dic. 2009. ilus
Article in English | LILACS | ID: lil-544559

ABSTRACT

Staphylococcus aureus es uno de los principales patógenos a nivel mundial. Durante los útimos años se ha reportado un incremento en el número de casos de S. aureus resistente a la meticilina adquiridos en la comunidad, tanto en niños como en adultos de los Estados Unidos y de otras partes del mundo. En el presente trabajo reportamos un caso de empiema necessitans y osteomielitis aguda en un niño de 19 meses de edad previamente sano. El presente reporte resalta la cambiante epidemiología de S. aureus tanto en la comunidad como en el medio hospitalario y la importancia de establecer guías apropiadas para el diagnóstico, el tratamiento y la vigilancia de este relevante problema de salud pública.


Staphylococcus aureus is a well recognized pathogen with global distribution. In recent years community-associated, methicillin-resistant S. aureus has emerged as an increasing cause of severe infections among adults and children. Herein, a case is reported of a previously healthy, 19-month-old male, who presented with empyema necessitans and acute osteomyelitis due to a community-associated, methicillin-resistant, S. aureus strain. This report highlights the evolving epidemiology of S. aureus, as important pathogen in the community as well as the hospital setting, and the importance of establishing appropriate guidelines for diagnosis, management and surveillance of this public health problem.


Subject(s)
Child , Empyema , Methicillin Resistance , Osteomyelitis , Pneumonia , Staphylococcus aureus , Vancomycin
SELECTION OF CITATIONS
SEARCH DETAIL